As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 3 of 4. 

My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes. 

Prior to co-founding Immunai, Noam had a career in both industry and academia. Noam has a double PhD in math and computer science and served as a postdoctoral researcher at MIT and Harvard. Noam also worked as an algorithms developer, consultant, and head of data science in several high-tech companies in Israel. Noam's extensive background in math, computer science, AI, and machine learning gives him a unique depth of experience that founders can learn from.

Please enjoy my conversation with Noam Solomon.

00:28 Intro

02:04 Episode starts, the human genome project and the alphabet used to read the book of the human immune system

05:10 Bringing an outsider's perspective to Immunai and their unique approach

08:07 Building the the Immunai team with both immunology and computer science experts who are not afraid to ask the stupid questions

12:10 Observing the hospital, pharma, AI landscape and how that shaped their philosophy of doing what's right even if they don’t know what they’re doing

19:00 Balancing both your naivete as a CEO with judging who’s advice to take

20:03 What is single cell multi-omics, the technology behind Immunai and what they learned from Netflix

24:44 How to embrace failure without creating a failure culture and other lessons learned from setting up their first lab

28:22 “Do you know how you dance with a gorilla?” and how to work with different pharma companies

33:05: Outro

https://www.immunai.com/ 

LinkedIn: https://www.linkedin.com/company/excedr/ 

Youtube: https://www.youtube.com/@excedr 

Instagram: https://www.instagram.com/excedr_inc 

Twitter: https://twitter.com/ExcedrInc 

Facebook: https://www.facebook.com/excedr 

TikTok: https://www.tiktok.com/@excedr 

Podcast Website: https://www.thebiotechstartupspodcast.com/ 

Immunai https://www.immunai.com/ 

Human Genome Project https://www.genome.gov/human-genome-project 

Single Cell Multi-Omics https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303816/ 

Recommender Systems https://en.wikipedia.org/wiki/Recommender_system 

What Is Bioinformatics https://www.excedr.com/blog/what-is-bioinformatics-and-computational-biology 

New Drug Application https://www.excedr.com/blog/new-drug-application-process 

Guide to the FDA Drug Approval Process https://www.excedr.com/blog/fda-drug-approval-process-guide 

Equipment Leasing for Laboratories https://www.excedr.com/leasing

Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support

Louis Voloch  https://www.linkedin.com/in/luisvoloch 

Ansuman Satpathy https://www.linkedin.com/in/ansuman-satpathy-3b386639/ 

Danny Wells https://www.linkedin.com/in/danny-wells-bb03453a/